Annual EBIT
-$25.95 M
-$1.09 M-4.41%
December 31, 2023
Summary
- As of February 8, 2025, VTVT annual earnings before interest & taxes is -$25.95 million, with the most recent change of -$1.09 million (-4.41%) on December 31, 2023.
- During the last 3 years, VTVT annual EBIT has fallen by -$13.84 million (-114.31%).
- VTVT annual EBIT is now -114.31% below its all-time high of -$12.11 million, reached on December 31, 2020.
Performance
VTVT EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$5.84 M
+$569.00 K+8.88%
September 30, 2024
Summary
- As of February 8, 2025, VTVT quarterly earnings before interest & taxes is -$5.84 million, with the most recent change of +$569.00 thousand (+8.88%) on September 30, 2024.
- Over the past year, VTVT quarterly EBIT has increased by +$569.00 thousand (+8.88%).
- VTVT quarterly EBIT is now -448.86% below its all-time high of $1.67 million, reached on December 31, 2020.
Performance
VTVT Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$22.31 M
+$2.70 M+10.78%
September 30, 2024
Summary
- As of February 8, 2025, VTVT TTM earnings before interest & taxes is -$22.31 million, with the most recent change of +$2.70 million (+10.78%) on September 30, 2024.
- Over the past year, VTVT TTM EBIT has increased by +$2.70 million (+10.78%).
- VTVT TTM EBIT is now -245.73% below its all-time high of -$6.45 million, reached on September 30, 2021.
Performance
VTVT TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
VTVT EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -4.4% | +8.9% | +10.8% |
| 3 y3 years | -114.3% | +19.0% | +14.8% |
| 5 y5 years | -27.5% | -22.5% | +6.7% |
VTVT EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -47.4% | at low | -42.8% | +38.4% | -26.7% | +23.7% |
| 5 y | 5-year | -114.3% | at low | -448.9% | +38.4% | -245.7% | +23.7% |
| alltime | all time | -114.3% | +52.8% | -448.9% | +60.0% | -245.7% | +59.6% |
VTv Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$5.84 M(-8.9%) | -$22.31 M(-10.8%) |
| Jun 2024 | - | -$6.41 M(+13.9%) | -$25.01 M(-3.1%) |
| Mar 2024 | - | -$5.63 M(+26.9%) | -$25.81 M(-6.5%) |
| Dec 2023 | -$25.95 M(+4.4%) | -$4.43 M(-48.1%) | -$27.61 M(-5.6%) |
| Sep 2023 | - | -$8.54 M(+18.4%) | -$29.26 M(+11.7%) |
| Jun 2023 | - | -$7.21 M(-2.9%) | -$26.18 M(+13.5%) |
| Mar 2023 | - | -$7.43 M(+22.1%) | -$23.06 M(-7.2%) |
| Dec 2022 | -$24.86 M(+41.2%) | -$6.08 M(+11.4%) | -$24.86 M(-12.0%) |
| Sep 2022 | - | -$5.46 M(+33.5%) | -$28.25 M(+17.0%) |
| Jun 2022 | - | -$4.09 M(-55.6%) | -$24.15 M(+15.6%) |
| Mar 2022 | - | -$9.22 M(-2.7%) | -$20.90 M(+18.7%) |
| Dec 2021 | -$17.60 M(+45.4%) | -$9.48 M(+597.4%) | -$17.60 M(+172.8%) |
| Sep 2021 | - | -$1.36 M(+61.6%) | -$6.45 M(-9.3%) |
| Jun 2021 | - | -$841.00 K(-85.8%) | -$7.11 M(-35.6%) |
| Mar 2021 | - | -$5.93 M(-454.1%) | -$11.04 M(-8.8%) |
| Dec 2020 | -$12.11 M(-39.5%) | $1.67 M(-183.0%) | -$12.11 M(-40.6%) |
| Sep 2020 | - | -$2.02 M(-57.7%) | -$20.38 M(-14.8%) |
| Jun 2020 | - | -$4.77 M(-31.8%) | -$23.92 M(+1.1%) |
| Mar 2020 | - | -$7.00 M(+6.0%) | -$23.65 M(+18.2%) |
| Dec 2019 | -$20.01 M | -$6.60 M(+18.8%) | -$20.01 M(+33.4%) |
| Sep 2019 | - | -$5.56 M(+23.5%) | -$15.00 M(+41.7%) |
| Jun 2019 | - | -$4.50 M(+34.1%) | -$10.58 M(-27.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$3.36 M(+111.7%) | -$14.61 M(-28.2%) |
| Dec 2018 | -$20.36 M(-59.9%) | -$1.58 M(+39.2%) | -$20.36 M(-35.8%) |
| Sep 2018 | - | -$1.14 M(-86.6%) | -$31.71 M(-24.6%) |
| Jun 2018 | - | -$8.53 M(-6.4%) | -$42.08 M(-8.8%) |
| Mar 2018 | - | -$9.11 M(-29.6%) | -$46.13 M(-9.1%) |
| Dec 2017 | -$50.76 M(-7.6%) | -$12.94 M(+12.5%) | -$50.76 M(-0.7%) |
| Sep 2017 | - | -$11.51 M(-8.6%) | -$51.13 M(-3.8%) |
| Jun 2017 | - | -$12.58 M(-8.3%) | -$53.13 M(-3.7%) |
| Mar 2017 | - | -$13.73 M(+3.1%) | -$55.16 M(+0.4%) |
| Dec 2016 | -$54.95 M(+39.7%) | -$13.32 M(-1.4%) | -$54.95 M(+4.3%) |
| Sep 2016 | - | -$13.51 M(-7.6%) | -$52.68 M(+8.2%) |
| Jun 2016 | - | -$14.62 M(+8.1%) | -$48.66 M(+11.6%) |
| Mar 2016 | - | -$13.52 M(+22.5%) | -$43.62 M(+10.9%) |
| Dec 2015 | -$39.33 M(+30.7%) | -$11.04 M(+16.3%) | -$39.33 M(+10.3%) |
| Sep 2015 | - | -$9.49 M(-0.8%) | -$35.66 M(+12.0%) |
| Jun 2015 | - | -$9.57 M(+3.7%) | -$31.84 M(+7.5%) |
| Mar 2015 | - | -$9.23 M(+25.2%) | -$29.62 M(-1.6%) |
| Dec 2014 | -$30.09 M(-17.3%) | -$7.37 M(+30.1%) | -$30.09 M(+32.5%) |
| Sep 2014 | - | -$5.67 M(-22.9%) | -$22.71 M(+33.2%) |
| Jun 2014 | - | -$7.35 M(-24.2%) | -$17.05 M(+75.8%) |
| Mar 2014 | - | -$9.70 M | -$9.70 M |
| Dec 2013 | -$36.38 M | - | - |
FAQ
- What is vTv Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for vTv Therapeutics?
- What is vTv Therapeutics annual EBIT year-on-year change?
- What is vTv Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for vTv Therapeutics?
- What is vTv Therapeutics quarterly EBIT year-on-year change?
- What is vTv Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for vTv Therapeutics?
- What is vTv Therapeutics TTM EBIT year-on-year change?
What is vTv Therapeutics annual earnings before interest & taxes?
The current annual EBIT of VTVT is -$25.95 M
What is the all time high annual EBIT for vTv Therapeutics?
vTv Therapeutics all-time high annual earnings before interest & taxes is -$12.11 M
What is vTv Therapeutics annual EBIT year-on-year change?
Over the past year, VTVT annual earnings before interest & taxes has changed by -$1.09 M (-4.41%)
What is vTv Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of VTVT is -$5.84 M
What is the all time high quarterly EBIT for vTv Therapeutics?
vTv Therapeutics all-time high quarterly earnings before interest & taxes is $1.67 M
What is vTv Therapeutics quarterly EBIT year-on-year change?
Over the past year, VTVT quarterly earnings before interest & taxes has changed by +$569.00 K (+8.88%)
What is vTv Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of VTVT is -$22.31 M
What is the all time high TTM EBIT for vTv Therapeutics?
vTv Therapeutics all-time high TTM earnings before interest & taxes is -$6.45 M
What is vTv Therapeutics TTM EBIT year-on-year change?
Over the past year, VTVT TTM earnings before interest & taxes has changed by +$2.70 M (+10.78%)